Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
Parent company rescues spin-off in turnaround plan -
Two largest block trades of the year have been Pfizer sell-downs in Haleon
-
Pfizer and Greek bailout fund selling as Applied Nutrition launches IPO
-
Four hybrids draw attention from rampant subordinated FIG market
-
Borrowers try to slide in before ECB meets on Thursday
-
At-the-market transaction to take advantage of strong results despite volatile market
